Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Zoetis found in breach of NOAH medicines promotion code
NOAH has ruled that Zoetis UK Limited has breached its Code of Practice for the Promotion of Animal Medicines.

The case involved unsubstantiated claims about CircoMax® Myco. 

The National Office of Animal Health (NOAH) has ruled that Zoetis UK Limited has breached its Code of Practice for the Promotion of Animal Medicines.

NOAH’s Code of Practice on the Promotion of Animal Medicines Committee met in June 2021 to discuss a case brought about by Hipra UK and Ireland Ltd. The case involved promotional claims made between March and May 2021 for Zoetis’ product, CircoMax® Myco.

Hipra UK and Ireland Ltd complained that Zoetis had made unsubstantiated claims that CircoMax® Myco provides the broadest protection and broader coverage against porcine circovirus (PCV2).

Among these claims included the phrases: “Stay one step ahead with the broadest, longest-lasting combined PCV2 and M.hyo* protection” and “Protect your pigs with Europe’s first and only dual PCV2 genotype vaccine. Broader coverage – against multiple PCV2 genotype and Mycoplasma hyopneumoniae”.

A NOAH press release reads: ‘Following comprehensive presentations from both parties and detailed analysis of the scientific and technical background, the Committee found that in their promotional statements, Zoetis promoted its CircoMax® Myco vaccine as providing better and broader protection against the PCV2 virus than other vaccines on the market and that the evidence presented was not sufficient to substantiate such claims.'

Further details about the case are available on the NOAH website.

 

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.